Disease-specific survival in patient-detected breast cancer

Clinical Breast Cancer

Volumn 7, Issue 2, 2006, Pages 133-140

  Kaplan, Henry G ^a   Malmgren, Judith A ^b,c  

^a SWEDISH MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Mammography; Recurrence; Screening; Self examination

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INVASION; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGISTRY; CANCER SURVIVAL; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; LOG RANK TEST; MAMMOGRAPHY; MASTECTOMY; MEDICAL RECORD; PROPORTIONAL HAZARDS MODEL; RECURRENCE RISK; STATISTICAL ANALYSIS;

EID: 33745911576     PISSN: 15268209     EISSN: None     Source Type: Journal    
DOI: 10.3816/CBC.2006.n.022     Document Type: Article

References (32)

1. U.S. Preventive Services Task Force. Guide to clinical preventive services: an assessment of the effectiveness of 169 interventions. Report of the U.S. Preventive Services Task Force. Baltimore, Md: Williams and Wilkins; 1989.
2. Hayward RSA, Steinberg EP, Ford DE, et al. Preventive Care Guidelines: 1991. Ann Int Med 1991; 114:768-783.
3. International Agency for Research on Cancer. Breast Cancer Screening/ IARC Working Group on the Evaluation of Cancer-Preventive Strategies. Lyon: IARC Press; 2002.
4. Mettlin C, Dodd GD. The American Cancer Society guidelines for the cancer-related checkup: an update. CA Cancer J Clin 1991; 41:279-282.
5. National Cancer Institute. Working Guidelines for Early Detection: Rationale and Supporting Evidence to Decrease Mortality. Bethesda, Md: National Cancer Institute; 1987.
6. National Institutes of Health Consensus Development Panel. National Institutes of Health Development Conference Statement: Breast Cancer Screening for Women Ages 40-49, January 21-23, 1997. JNCI Monographs 1997; 22:vii-xii.
7. Tabar L, Fagerberg G, Duffy SW, et al. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 1992; 30:187-210.
8. Shapiro S. Evidence on screening for breast cancer from a randomized trial. Cancer 1977; 39:2772-2782.
9. Coburn NG, Chung MA, Fulton J, et al. Decreased breast cancer tumor size, stage and mortality in Rhode Island: an example of a well-screened population. Cancer Control 2004; 11:222-230.
10. Ernst MF, Voogd AC, Coeburgh JWW, et al. Breast carcinoma diagnosis, treatment, and prognosis before and after the introduction of mass mammographic screening. Cancer 2004; 100:1337-1344.
11. Joensuu H, Lehtmaki T, Holli K, et al. Risk for distant recurrence of breast cancer detected by mammography screening or other methods. JAMA 2004; 292:1064-1073.
12. Shen Y, Yang Y, Inoue LYT, et al. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials. J Natl Cancer Inst 2005; 97:1195-1203.
13. Nemoto T, Natarajan N, Smart CR, et al. Patterns of breast cancer detection in the United States. J Surg Oncol 1982; 21: 183-188.
14. Senie RT, Lesser M, Kinne DW, et al. Method of tumor detection influences disease-free survival of women with breast carcinoma. Cancer 1994; 73:1666-1672.
15. Reeves MJ, Newcomb PA, Remington PL, et al. Determinants of breast cancer detection among Wisconsin (United States) women, 1988-90. Cancer Causes Control 1995; 6:103-111.
16. Newcomer LM, Newcomb PA, Trentham-Dietz A, et al. Detection method and breast carcinoma histology. Cancer 2002; 95:470-477.
17. Fleming ID, Cooper JS, Henson DE, et al. AJCC Cancer Staging Manual. 5th ed. Philadelphia: Lippincott and Raven; 1998.
18. SPSS©. Version 13.0. Chicago, Il: SPSS, Inc; 2001.
19. R. Development Core Team (2004). R: a language and environment for statistical computing. R Foundation for Statistical Computing. Vienna, Austria. Available at: http://www.R-project.org. Accessed March 10, 2005.
20. Cady B, Michaelson JS. The life-sparing potential of mammographic screening. Cancer 2001; 91:1699-1703.
21. Klemi PJ, Joensuu H, Toikkanen S, et al. Aggressiveness of breast cancers found with and without screening. BMJ 1992; 304:467-469.
22. Webster LR, Bilous AM, Willis L, et al. Histopathologic indicators of breast cancer biology: insights from population mammographic screening. B J Cancer 2005; 92:1366-1371.
23. Baxter N. Preventive health care, 2001 update: Should women be routinely taught breast self-examination to screen for breast cancer? CMAJ 2001; 164:1837-1846.
24. Smith RA, Saslow D, Sawyer KA, et al. American Cancer Society guidelines for breast cancer screening update 2003. CA Cancer J Clin 2003; 53:141-169.
25. Fletcher SW, Elmore JG. Mammographic screening for breast cancer. N Engl J Med 2003; 348:1672-1680.
26. White E, Miglioretti DL, Yankaskas BC, et al. Biennial versus annual mammography and the risk of late-stage breast cancer. J Natl Cancer Inst 2004; 96:1832-1839.
27. Buist DSM, Porter PL, Lehman C, et al. Factors contributing to mammography failure in women aged 40-49 years. J Natl Cancer Inst 2004; 96:1432-1440.
28. Barth RJ, Gibson GR, Carney PA, et al. Detection of breast cancer on screening mammography allows patient to be treated with less-toxic therapy. Am J Roentgenol 2005; 184:324-329.
29. Thomas DB, Gao DL, Ray RM, et al. Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst 2002; 94:1445-1457.
30. Porter PL, El-Bastawissi AY, Mandelson MT, et al. Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 1999; 91:2020-2028.
31. Moody-Ayers SY, Wells CK, Feinstein AR. "Benign" tumors and "early detection" in mammography-screened patients of a natural cohort with breast cancer. Arch Intern Med 2000; 160:1109-1115.
32. Klemi PJ, Parvinen I, Pylkkanen L, et al. Significant improvement in breast cancer survival through population-based mammography screening. Breast 2003; 12:308-313.